Krsnaa Diagnostics to Meet Investors/Analysts on Feb 13
Krsnaa Diagnostics Limited will hold a one-on-one physical meeting with Akash Ganga Limited on February 13, 2026, in Mumbai. Discussions will be based on publicly available information only.
This is a standard disclosure of an upcoming investor interaction, which is a routine part of corporate communication. It does not involve any new financial results, strategic decisions, or significant business updates.
The announcement is a routine intimation about an upcoming investor meeting and does not contain any material new information that would significantly impact the stock price or company's outlook.
Krsnaa Diagnostics Limited has announced that its officials will be meeting with investors and analysts. The meeting is scheduled to take place on February 13, 2026, in Mumbai.
This will be a one-on-one interaction with Akash Ganga Limited and will be conducted physically, starting from 11:00 Hrs. (IST) onwards. The discussions will be based solely on publicly available information, and no unpublished price sensitive information (UPSI) is intended to be shared.
The company has noted that the schedule is subject to change due to unforeseen circumstances on the part of either the analyst/institutional investor or the company.
What to do with a filing like this
Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.